Maxor National Pharmacy Services, LLC (“Maxor”), today announced that Vertex Pharmaceuticals Inc. has now included Maxor Specialty, comprised of IV Solutions and Pharmaceutical Specialties (“PSI”), in its specialty pharmacy network. Effectively immediately, patients may now utilize Maxor Specialty for Orkambi® and Kalydeco®, two leading medications used in the treatment of certain types of Cystic Fibrosis (“CF”).
Cystic Fibrosis (CF) is a genetic condition that affects the body's lungs, sweat glands, and digestive system.
The CF community is a support group that provides tools and education to CF patients and their families. Maxor Specialty is a part of this community. We manage and care for the complete needs of our CF patients.
Rare Disease Day, launched in Europe in 2008, is held the last day of February every year and seeks to raise awareness of the impact that rare or orphan diseases have on the lives of patients and those who care for them. The USA joined the campaign in 2009 and over 80 countries throughout the world participated in 2016. The theme for 2017 is “RESEARCH” and the slogan is “With research, possibilities are limitless.”